Latest News about Phase 3 Trial
Recent news which mentions Phase 3 Trial
Why Eiger BioPharmaceuticals Stock Is Jumping Today
March 17, 2022
From Benzinga
Eli Lilly's Phase 3 Jardiance Study Stopped Early Due To Clear Positive Efficacy In Kidney Disease
March 16, 2022
Tickers
LLY
From Benzinga
Apellis' Pegcetacoplan Showed Continuous, Meaningful Effects At Month 18 In Geographic Atrophy Studies
March 16, 2022
Tickers
APLS
From Benzinga
From Benzinga
Junshi Biosciences - Coherus Toripalimab Chemo Combo Met Survival Endpoints In Lung Cancer Setting
March 15, 2022
Tickers
CHRS
From Benzinga
From Benzinga
AbbVie's Migraine Treatment Drug Touts Encouraging Data In Preventive Treatment Setting
March 10, 2022
Tickers
ABBV
From Benzinga
From Benzinga
See Why Did Finch Therapeutics Halt Enrolment In Late-Stage C. Difficile Infection Trial
March 02, 2022
Tickers
FNCH
From Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
February 24, 2022
Tickers
KRTX
From Benzinga
From Benzinga
From Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
February 16, 2022
From Benzinga
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
From Benzinga
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
February 15, 2022
From Benzinga
Data Committee Recommends Veru's COVID-19 Trial To Continue Unmodified
February 14, 2022
Tickers
VERU
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
